Suppr超能文献

人源布鲁顿酪氨酸激酶在活性和非活性构象下的结构揭示了 TEC 家族激酶的激活机制。

Structures of human Bruton's tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases.

机构信息

Biogen Idec, Inc., Drug Discovery Department, 12 Cambridge Center, Cambridge, Massachusetts 02142, USA.

出版信息

Protein Sci. 2010 Mar;19(3):429-39. doi: 10.1002/pro.321.

Abstract

Bruton's tyrosine kinase (BTK), a member of the TEC family of kinases, plays a crucial role in B-cell maturation and mast cell activation. Although the structures of the unphosphorylated mouse BTK kinase domain and the unphosphorylated and phosphorylated kinase domains of human ITK are known, understanding the kinase selectivity profiles of BTK inhibitors has been hampered by the lack of availability of a high resolution, ligand-bound BTK structure. Here, we report the crystal structures of the human BTK kinase domain bound to either Dasatinib (BMS-354825) at 1.9 A resolution or to 4-amino-5-(4-phenoxyphenyl)-7H-pyrrolospyrimidin- 7-yl-cyclopentane at 1.6 A resolution. This data provides information relevant to the development of small molecule inhibitors targeting BTK and the TEC family of nonreceptor tyrosine kinases. Analysis of the structural differences between the TEC and Src families of kinases near the Trp-Glu-Ile motif in the N-terminal region of the kinase domain suggests a mechanism of regulation of the TEC family members.

摘要

布鲁顿酪氨酸激酶(BTK)是 TEC 激酶家族的成员,在 B 细胞成熟和肥大细胞激活中发挥着关键作用。虽然未磷酸化的小鼠 BTK 激酶结构域和未磷酸化及磷酸化的人 ITK 激酶结构域的结构是已知的,但由于缺乏高分辨率的配体结合 BTK 结构,因此理解 BTK 抑制剂的激酶选择性特征一直受到阻碍。在这里,我们报道了与人 BTK 激酶结构域结合的 Dasatinib(BMS-354825)的晶体结构,分辨率为 1.9Å,或与 4-氨基-5-(4-苯氧基苯基)-7H-吡咯并[2,3-d]嘧啶-7-基-环戊烷的晶体结构,分辨率为 1.6Å。该数据为开发针对 BTK 和 TEC 家族非受体酪氨酸激酶的小分子抑制剂提供了相关信息。对激酶结构域 N 端区域中 Trp-Glu-Ile 基序附近 TEC 和 Src 激酶家族之间结构差异的分析表明了 TEC 家族成员的调节机制。

相似文献

2
X-ray crystal structure of bone marrow kinase in the x chromosome: a Tec family kinase.
Chem Biol Drug Des. 2011 Nov;78(5):739-48. doi: 10.1111/j.1747-0285.2011.01230.x. Epub 2011 Sep 21.
4
The accessory factor Nef links HIV-1 to Tec/Btk kinases in an Src homology 3 domain-dependent manner.
J Biol Chem. 2014 May 30;289(22):15718-28. doi: 10.1074/jbc.M114.572099. Epub 2014 Apr 10.
8
Reconstitution of Btk signaling by the atypical tec family tyrosine kinases Bmx and Txk.
J Biol Chem. 1999 May 7;274(19):13577-85. doi: 10.1074/jbc.274.19.13577.
9
Discovery of a Novel Class of Covalent Dual Inhibitors Targeting the Protein Kinases BMX and BTK.
Int J Mol Sci. 2020 Dec 4;21(23):9269. doi: 10.3390/ijms21239269.
10
Identification of the binding site for Gqalpha on its effector Bruton's tyrosine kinase.
Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12197-201. doi: 10.1073/pnas.95.21.12197.

引用本文的文献

3
BTK inhibitors and next-generation BTK-targeted therapeutics for B-cell malignancies.
Arch Pharm Res. 2025 May 8. doi: 10.1007/s12272-025-01546-0.
5
Computational Investigation of the Covalent Inhibition Mechanism of Bruton's Tyrosine Kinase by Ibrutinib.
J Chem Inf Model. 2024 Apr 22;64(8):3488-3502. doi: 10.1021/acs.jcim.4c00023. Epub 2024 Mar 28.
8
PON-Fold: Prediction of Substitutions Affecting Protein Folding Rate.
Int J Mol Sci. 2023 Aug 21;24(16):13023. doi: 10.3390/ijms241613023.

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
Hybrid compound design to overcome the gatekeeper T338M mutation in cSrc.
J Med Chem. 2009 Jul 9;52(13):3915-26. doi: 10.1021/jm9002928.
3
Activation loop phosphorylation modulates Bruton's tyrosine kinase (Btk) kinase domain activity.
Biochemistry. 2009 Mar 10;48(9):2021-32. doi: 10.1021/bi8019756.
4
Crystal structures of the Lyn protein tyrosine kinase domain in its Apo- and inhibitor-bound state.
J Biol Chem. 2009 Jan 2;284(1):284-291. doi: 10.1074/jbc.M807850200. Epub 2008 Nov 4.
5
Searching protein structure databases with DaliLite v.3.
Bioinformatics. 2008 Dec 1;24(23):2780-1. doi: 10.1093/bioinformatics/btn507. Epub 2008 Sep 25.
6
The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib.
Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13283-8. doi: 10.1073/pnas.0702654104. Epub 2007 Aug 7.
7
Activation mechanism and steady state kinetics of Bruton's tyrosine kinase.
J Biol Chem. 2007 Mar 23;282(12):8768-76. doi: 10.1074/jbc.M609920200. Epub 2007 Jan 30.
8
Discovery of selective irreversible inhibitors for Bruton's tyrosine kinase.
ChemMedChem. 2007 Jan;2(1):58-61. doi: 10.1002/cmdc.200600221.
9
Anti-breast cancer activity of LFM-A13, a potent inhibitor of Polo-like kinase (PLK).
Bioorg Med Chem. 2007 Jan 15;15(2):800-14. doi: 10.1016/j.bmc.2006.10.050. Epub 2006 Oct 26.
10
BTKbase: the mutation database for X-linked agammaglobulinemia.
Hum Mutat. 2006 Dec;27(12):1209-17. doi: 10.1002/humu.20410.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验